Compare CAKE & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CAKE | GRFS |
|---|---|---|
| Founded | 1972 | 1940 |
| Country | United States | Spain |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.2B |
| IPO Year | 1996 | 2008 |
| Metric | CAKE | GRFS |
|---|---|---|
| Price | $103.61 | $7.82 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 16 | 2 |
| Target Price | ★ $60.31 | $10.15 |
| AVG Volume (30 Days) | ★ 1.6M | 333.8K |
| Earning Date | 04-29-2026 | 07-28-2022 |
| Dividend Yield | ★ 1.92% | 1.80% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.43 | N/A |
| Revenue | ★ $3,751,806,000.00 | N/A |
| Revenue This Year | $6.14 | $4.49 |
| Revenue Next Year | $6.65 | $6.42 |
| P/E Ratio | $44.12 | ★ $18.67 |
| Revenue Growth | ★ 4.75 | N/A |
| 52 Week Low | $43.07 | $6.96 |
| 52 Week High | $118.46 | $10.23 |
| Indicator | CAKE | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 46.05 | 49.35 |
| Support Level | $102.42 | $7.62 |
| Resistance Level | $117.12 | $8.36 |
| Average True Range (ATR) | 3.57 | 0.15 |
| MACD | -1.72 | -0.02 |
| Stochastic Oscillator | 10.40 | 29.09 |
The Cheesecake Factory Inc is a restaurant company that owns and operates multiple casual dining brands across the United States and Canada under brands that include The Cheesecake Factory, North Italia, Flower Child, and additional brands within its Fox Restaurant Concepts portfolio. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, Other FRC, and Other. The majority of the company's revenue comes from the Cheesecake Factory restaurants segment.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.